Identifying the single "most volatile" stock on public markets changes constantly, as extreme volatility typically plagues leveraged exchange-traded funds (ETFs), distressed micro-cap equities, speculative pre-revenue biotechnology firms, and heavily shorted meme stocks. Companies experiencing sudden regulatory investigations, binary clinical trial outcomes, or massive speculative trading volume frequently register extreme daily price swings and beta values well above standard market averages.